Oncogenic exon 2 mutations in Mediator subunit MED12 disrupt allosteric activation of cyclin C-CDK8/19
暂无分享,去创建一个
Min Ju Park | Robert S. Schenken | Serdar E. Bulun | Lauri A. Aaltonen | Ayman Al-Hendy | L. Aaltonen | T. Boyer | Qiwei Yang | S. Bulun | A. Al-Hendy | R. Schenken | Qiwei Yang | Hailian Shen | Jason M. Spaeth | Jaana H. Tolvanen | Courtney Failor | Jennifer F. Knudtson | Jessica McLaughlin | Sunil K. Halder | Thomas G. Boyer | S. Halder | J. McLaughlin | J. Knudtson | Jaana Tolvanen | Hailian Shen | J. Spaeth | Courtney M Failor
[1] W. Hehenkamp,et al. Review of nonsurgical/minimally invasive treatments for uterine fibroids , 2012, Current opinion in obstetrics & gynecology.
[2] Seokjoong Kim,et al. Mediator Is a Transducer of Wnt/β-Catenin Signaling* , 2006, Journal of Biological Chemistry.
[3] Md Soriful Islam,et al. Uterine leiomyoma: available medical treatments and new possible therapeutic options. , 2013, The Journal of clinical endocrinology and metabolism.
[4] Jun-Yuan Ji,et al. Dysregulation of CDK8 and Cyclin C in tumorigenesis. , 2011, Journal of genetics and genomics = Yi chuan xue bao.
[5] A. Al-Hendy,et al. Medical Treatment of Uterine Leiomyoma , 2012, Reproductive Sciences.
[6] T. Boyer,et al. Silencing Med12 Gene Reduces Proliferation of Human Leiomyoma Cells Mediated via Wnt/&bgr;-Catenin Signaling Pathway , 2016, Endocrinology.
[7] J. Treisman,et al. Pygopus activates Wingless target gene transcription through the mediator complex subunits Med12 and Med13 , 2008, Proceedings of the National Academy of Sciences.
[8] J. Treisman,et al. Two subunits of the Drosophila mediator complex act together to control cell affinity , 2003, Development.
[9] K. Bhanot,et al. Complications and Reinterventions in Uterine Artery Embolization for Symptomatic Uterine Fibroids: A Literature Review and Meta Analysis , 2013, CardioVascular and Interventional Radiology.
[10] S. Bulun,et al. Uterine fibroids , 2001, The Lancet.
[11] L. Aaltonen,et al. Integrated data analysis reveals uterine leiomyoma subtypes with distinct driver pathways and biomarkers , 2016, Proceedings of the National Academy of Sciences.
[12] A. Clark,et al. Mediator kinase module and human tumorigenesis , 2015, Critical reviews in biochemistry and molecular biology.
[13] Sohail Malik,et al. The metazoan Mediator co-activator complex as an integrative hub for transcriptional regulation , 2010, Nature Reviews Genetics.
[14] R. Bernards,et al. MED12 Controls the Response to Multiple Cancer Drugs through Regulation of TGF-β Receptor Signaling , 2012, Cell.
[15] J. Kuriyan,et al. The Conformational Plasticity of Protein Kinases , 2002, Cell.
[16] B. Chait,et al. Reconstitution of active human core Mediator complex reveals a pivotal role of the MED14 subunit , 2014, Nature Structural &Molecular Biology.
[17] L. Aaltonen,et al. MED12, the Mediator Complex Subunit 12 Gene, Is Mutated at High Frequency in Uterine Leiomyomas , 2011, Science.
[18] J. Treisman,et al. Requirements for mediator complex subunits distinguish three classes of notch target genes at the Drosophila wing margin , 2011, Developmental dynamics : an official publication of the American Association of Anatomists.
[19] S. Bulun,et al. Endocrinology of uterine fibroids: steroid hormones, stem cells, and genetic contribution , 2015, Current opinion in obstetrics & gynecology.
[20] P. Cramer,et al. Core Mediator structure at 3.4 Å extends model of transcription initiation complex , 2017, Nature.
[21] Li-Huei Tsai,et al. Cyclin-dependent kinases: a family portrait , 2009, Nature Cell Biology.
[22] R. Huber,et al. The structure of CDK8/CycC implicates specificity in the CDK/cyclin family and reveals interaction with a deep pocket binder. , 2011, Journal of molecular biology.
[23] Y. Ohkuma,et al. Identification of target genes for the CDK subunits of the Mediator complex , 2011, Genes to cells : devoted to molecular & cellular mechanisms.
[24] T. Hunter,et al. The Protein Kinase Complement of the Human Genome , 2002, Science.
[25] D. Taatjes,et al. The complex structure and function of Mediator , 2017, The Journal of Biological Chemistry.
[26] J. Byrd,et al. Somatic MED12 mutations are associated with poor prognosis markers in chronic lymphocytic leukemia , 2014, Oncotarget.
[27] U. Surti,et al. Med12 gain-of-function mutation causes leiomyomas and genomic instability. , 2015, The Journal of clinical investigation.
[28] Boris Zybailov,et al. A set of consensus mammalian mediator subunits identified by multidimensional protein identification technology. , 2004, Molecular cell.
[29] Elizabeth A Stewart,et al. Clinical practice. Uterine fibroids. , 2015, The New England journal of medicine.
[30] M. Werner,et al. Toward understanding of the mechanisms of Mediator function in vivo: Focus on the preinitiation complex assembly , 2017, Transcription.
[31] Min Ju Park,et al. Uterine leiomyoma-linked MED12 mutations disrupt mediator-associated CDK activity. , 2014, Cell reports.
[32] Swe Swe Myint,et al. Exome sequencing identifies highly recurrent MED12 somatic mutations in breast fibroadenoma , 2014, Nature Genetics.
[33] D. Taatjes,et al. A Kinase-Independent Role for Cyclin-Dependent Kinase 19 in p53 Response , 2017, Molecular and Cellular Biology.
[34] L. Aaltonen,et al. Somatic MED12 mutations in uterine leiomyosarcoma and colorectal cancer , 2012, British Journal of Cancer.
[35] C. Tomomori-Sato,et al. A conserved Mediator–CDK8 kinase module association regulates Mediator–RNA polymerase II interaction , 2013, Nature Structural &Molecular Biology.
[36] H. Bourbon,et al. Comparative genomics supports a deep evolutionary origin for the large, four-module transcriptional mediator complex , 2008, Nucleic acids research.
[37] Roger D Kornberg,et al. Mediator and the mechanism of transcriptional activation. , 2005, Trends in biochemical sciences.
[38] M. Hill,et al. Leiomyoma: genetics, assisted reproduction, pregnancy and therapeutic advances , 2012, Journal of Assisted Reproduction and Genetics.
[39] Min Ju Park,et al. Mutations in Exon 1 Highlight the Role of MED12 in Uterine Leiomyomas , 2014, Human mutation.
[40] W. Catherino,et al. Uterine fibroids , 2016, Nature Reviews Disease Primers.
[41] S. Ishii,et al. Mediator Modulates Gli3-Dependent Sonic Hedgehog Signaling , 2006, Molecular and Cellular Biology.
[42] L. Johnson,et al. The structural basis for control of eukaryotic protein kinases. , 2012, Annual review of biochemistry.
[43] T. Nagase,et al. Mutual Exclusivity of MED12/MED12L, MED13/13L, and CDK8/19Paralogs Revealed within the CDK-Mediator Kinase Module , 2013 .
[44] D. Taatjes,et al. The Human CDK8 Subcomplex Is a Histone Kinase That Requires Med12 for Activity and Can Function Independently of Mediator , 2008, Molecular and Cellular Biology.
[45] L. Aaltonen,et al. Genomics of uterine leiomyomas: insights from high-throughput sequencing. , 2014, Fertility and sterility.
[46] Susan S. Taylor,et al. Regulation of protein kinases; controlling activity through activation segment conformation. , 2004, Molecular cell.
[47] C. Schwartz,et al. MED12 mutations link intellectual disability syndromes with dysregulated GLI3-dependent Sonic Hedgehog signaling , 2012, Proceedings of the National Academy of Sciences.
[48] E. H. Schmidt,et al. A randomized, controlled clinical trial comparing the effects of aromatase inhibitor (letrozole) and gonadotropin-releasing hormone agonist (triptorelin) on uterine leiomyoma volume and hormonal status. , 2010, Fertility and sterility.
[49] Gemma K. Alderton. Metastasis: Shedding is no easy task , 2014, Nature Reviews Cancer.
[50] Y. Ohkuma,et al. Human mediator kinase subunit CDK11 plays a negative role in viral activator VP16‐dependent transcriptional regulation , 2008, Genes to cells : devoted to molecular & cellular mechanisms.
[51] Dylan J. Taatjes,et al. The Mediator complex: a central integrator of transcription , 2015, Nature Reviews Molecular Cell Biology.
[52] M. Washburn,et al. Mediator structure and rearrangements required for holoenzyme formation , 2017, Nature.
[53] Swe Swe Myint,et al. Genomic landscapes of breast fibroepithelial tumors , 2015, Nature Genetics.